000 | 03301nam a22004935i 4500 | ||
---|---|---|---|
001 | 978-94-017-9165-6 | ||
003 | DE-He213 | ||
005 | 20160405113007.0 | ||
007 | cr nn 008mamaa | ||
008 | 141117s2015 ne | s |||| 0|eng d | ||
020 |
_a9789401791656 _9978-94-017-9165-6 |
||
024 | 7 |
_a10.1007/978-94-017-9165-6 _2doi |
|
050 | 4 | _aRC261-271 | |
072 | 7 |
_aMJCL _2bicssc |
|
072 | 7 |
_aMED062000 _2bisacsh |
|
082 | 0 | 4 |
_a614.5999 _223 |
100 | 1 |
_aFaguet, Guy. _eauthor. |
|
245 | 1 | 4 |
_aThe Conquest of Cancer _h[electronic resource] : _bA distant goal / _cby Guy Faguet. |
264 | 1 |
_aDordrecht : _bSpringer Netherlands : _bImprint: Springer, _c2015. |
|
300 |
_aXV, 249 p. 26 illus., 7 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aPreface. Part I An Historical overview of the war on cancer. The four-decade journey to the National Cancer Act of 1971. Part II Cancer through the ages -- An historical overview: From prehistory to WW11 -- Our current knowledge -- Environmental carcinogens -- Part III Cancer statistics -- Assessing the enormity of the problem -- An uncontrolled problem -- Part IV How is advanced cancer treated?-The cancer-cell kill paradigm and beyond.- Complementary and alternative medicine -- The cell-kill paradigm: Bleak outcomes. Part V Stakeholders' role in the status quo -- The role of the National Cancer Institute -- Factors that impact Oncology research and practice -- The complex physician-patient interaction: Expectations vs. reality. Part VI A paradigm shift in cancer management.- Prevention & Early detection -- The holistic management of advanced cancer: A three-stage blueprint. Conclusions. References. Index. | |
520 | _aBased on 30 years of clinical and research experience, backed by a careful assessment of four decades of published data, Dr. Faguet documented in The War on Cancer (Springer 2005), early advances in cancer treatment and patient survival that soon stalled. Ten years later, and after an exhaustive analysis of evidence-based data available through 2013 that incorporates 755 references, he reveals the root causes of the stagnation in cancer control, including the role played by major stakeholders, and advocates a coordinated national effort, akin to the Apollo program, to unveil the causes of cancer and their mastery. In the interim, Dr. Faguet urges caregivers to manage patients according to the four ethical principles of beneficence, non-maleficence, respect for patients’ autonomy, and justice especially at the end of life. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aCancer research. | |
650 | 0 | _aHuman genetics. | |
650 | 0 | _aMolecular biology. | |
650 | 0 | _aOncology. | |
650 | 1 | 4 | _aBiomedicine. |
650 | 2 | 4 | _aCancer Research. |
650 | 2 | 4 | _aOncology. |
650 | 2 | 4 | _aMolecular Medicine. |
650 | 2 | 4 | _aMedicine/Public Health, general. |
650 | 2 | 4 | _aHuman Genetics. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9789401791649 |
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-94-017-9165-6 |
912 | _aZDB-2-SBL | ||
999 |
_c4321 _d4321 |